1. Tumor targeted porphyrin-based metal–organic framework for photodynamic and checkpoint blockade immunotherapy.
- Author
-
Liu, Yulong, Zou, Bocheng, Yang, Kang, Jiao, Liqin, Zhao, Huifang, Bai, Peirong, Tian, Yanzhang, and Zhang, Ruiping
- Subjects
- *
METALLOPORPHYRINS , *METAL-organic frameworks , *REACTIVE oxygen species , *TUMOR antigens , *ACOUSTIC imaging , *IMMUNOTHERAPY , *TUMOR growth - Abstract
Photodynamic therapy (PDT) has become a promising approach and non-invasive modality for cancer treatment, however the therapeutic effect of PDT is limited in tumor metastasis and local recurrence. Herein, a tumor targeted nanomedicine (designated as PCN@HA) is constructed for enhanced PDT against tumors. By modified with hyaluronic acid (HA), which could target the CD44 receptor that expressed on the cancer cells, the targeting ability of PCN@HA has been enhanced. Under light irradiation, PCN@HA can produce cytotoxic singlet oxygen (1O 2) and kill cancer cells, then eliminate tumors. Furthermore, PCN@HA exhibits fluorescence (FL)/ photoacoustic (PA) effects for multimodal imaging-guided cancer treatment. And PCN@HA-mediated PDT also can induce immunogenic cell death (ICD) and stimulate adaptive immune responses by releasing of tumor antigens. By combining with anti-PD-L1 checkpoint blockade therapy, it can not only effectively suppress the growth of primary tumor, but also inhibit the metastatic tumor growth. • PCN@HA achieved fluorescence/photoacoustic dual-mode imaging guided cancer treatment. • PCN@HA-mediated PDT induced immunogenic cell death. • By combining with anti-PD-L1 checkpoint blockade therapy, both primary tumor and metastatic tumor were suppressed. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF